NARDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nardil, and what generic alternatives are available?
Nardil is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in NARDIL is phenelzine sulfate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenelzine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nardil
A generic version of NARDIL was approved as phenelzine sulfate by NOVEL LABS INC on December 8th, 2010.
Summary for NARDIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,162 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for NARDIL |
| What excipients (inactive ingredients) are in NARDIL? | NARDIL excipients list |
| DailyMed Link: | NARDIL at DailyMed |
Recent Clinical Trials for NARDIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Boehringer Ingelheim | Phase 1 |
| Southern Medical Day Care Centre | Phase 1 |
| EpiAxis Therapeutics | Phase 1 |
Pharmacology for NARDIL
| Drug Class | Monoamine Oxidase Inhibitor |
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for NARDIL
US Patents and Regulatory Information for NARDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | NARDIL | phenelzine sulfate | TABLET;ORAL | 011909-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
